Election 2014
SENSEX NIFTY

Ranbaxy Laboratories

Apr 23, 2014 at 14:14 | Source: CNBC-TV18
Jitendra Panda of Peerless Securities recommends buying Ranbaxy Laboratories as the stock may test Rs 500.
Apr 22, 2014 at 11:17 | Source: CNBC-TV18
SP Tulsian of sptulsian.com feels that Sun Pharmaceutical Industries may slip below Rs 600.
Apr 21, 2014 at 16:47 | Source: CNBC-TV18
Praful Bohra of Nirmal Bang believes the balance sheets of pharma companies remain pretty reasonable for large cap stocks. Even among midcaps, there are some names where there is lot of value remaining.
Apr 21, 2014 at 14:42 | Source: CNBC-TV18
Nischal Maheshwari of Edelweiss Financial Services is neutral on pharmaceutical space.
Apr 18, 2014 at 14:32 | Source: Reuters
Medicines produced in India, which supplies about 40 percent of generic and over-the-counter drugs sold in the United States, have come under increased scrutiny by the Food and Drug Administration over the past year.
Apr 15, 2014 at 14:16 | Source: Reuters
The Suprax recall is the second for India's fourth-largest drugmaker by sales, after pulling nearly 65,000 bottles from the US in January last year because of discoloration.
Apr 12, 2014 at 11:38 | Source: Moneycontrol.com
Ranbaxy Laboratories has informed that a meeting of the Board of Directors of the company will be held on May 9, 2014 to consider and approve audited financial results for the quarter and 15 months period ended March 31, 2014. Further the company has informed that, trading window will remain closed from April 26, 2014 to May 10, 2014 (both days
Apr 11, 2014 at 22:29 | Source: PTI
Through the open offer, Sun Pharma plans to acquire more than 96 lakh shares of Zenotech, amounting to 28.1 percent. The price would be Rs 19 per share translating to an aggregate of Rs 18.42 crore, according to regulatory filing by Zenotech.
Apr 11, 2014 at 09:57 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips.in, pharma stocks like Divis Labs, Sun Pharma,Ranbaxy, Strides Arcolab and Cipla will get astrological support.
Apr 10, 2014 at 22:22 | Source: CNBC-TV18
DG Shah, Secretary General, Indian Pharmaceutical Association said, Inbound acquisitions are faster -- this needs to be compensated by MNCs. Companies will look for complimentary portfolios - larger companies are hungry for acquisitions. We have seen Elder-Torrent and now Sun-Ranbaxy, it has created a pressure."
Messages on Ranbaxy Laboratories »

Market Statistician

Platinum Member

8035 Followers

Ranbaxy Labs  

At 14:14 hrs, Ranbaxy Laboratories was trading at Rs 473.30 up 1.81%, with a huge increase in its volume of shares traded. Till now over 431,386 shares were traded as compared to its 5-day average of 174,793 shares.

2.15 PM Apr 23rd

Jitendra Panda

Platinum Member

16 Followers

Ranbaxy Labs  

Will you buy Ranbaxy Laboratories for long term?

2.14 PM Apr 23rd

Market Statistician

Platinum Member

8035 Followers

Ranbaxy Labs  

At 13:14 hrs, Ranbaxy Laboratories was trading at Rs 475.50 up 2.28%, with a huge increase in its volume of shares traded. Till now over 371,952 shares were traded as compared to its 5-day average of 174,793 shares.

1.15 PM Apr 23rd

Web Messenger

Platinum Member

209446 Followers

Sun Pharma  

Source:NDTV Profit - New Delhi: Ranbaxy Laboratories will cease to exist as a company after completion of the $4 billion merger with Sun Pharmaceuticals, although its brands will be kept alive in over 100 markets. "The Ranbaxy entity will be merged into Sun Pharma and Sun ...

7.01 PM Apr 20th

BSE/NSE Announcer

Platinum Member

2365 Followers

Ranbaxy Labs  

Ranbaxy Laboratories Limited has informed the Exchange that the ESOPs Allotment Committee of Directors vide Resolution by Circulation passed on April 14, 2014, allotted 26,747 Equity Shares on exercise of stock options under the Employees Stock Option Scheme(s) of the Company. The paid-up Equity

10.27 AM Apr 15th

BSE/NSE Announcer

Platinum Member

2365 Followers

Ranbaxy Labs  

Ranbaxy Laboratories Ltd has informed BSE that the ESOPs Allotment Committee of Directors vide Resolution by Circulation passed on April 14, 2014, allotted 26,747 Equity Shares on exercise of stock options under the Employees Stock OptionScheme(s) of the Company. The paid-up Equity Share

1.16 PM Apr 14th

sheibu1234

Platinum Member

210 Followers

Ranbaxy Labs  

Sun Pharma will make an open offer worth Rs. 18.4 crore to acquire a little over 28 per cent stake in Zenotech Laboratories Ltd. The proposal comes in the wake of Sun Pharma`s proposed $4-billion deal to merge Ranbaxy Laboratories with itself as the latter holds significant stake

3.19 PM Apr 13th

BSE/NSE Announcer

Platinum Member

2365 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has informed that a meeting of the Board of Directors of the company will be held on May 9, 2014 to consider and approve audited financial results for the quarter and 15 months period ended March 31, 2014. Further the company has informed that, trading window will remain closed

11.38 AM Apr 12th

Web Messenger

Platinum Member

209446 Followers

Sun Pharma  

Source:NDTV Profit - The $4 billion merger deal of Ranbaxy with Sun Pharma is expected to close by the end of 2014, Japanese drug maker Daiichi Sankyo, which holds majority stake in the former, said today. Daiichi had acquired a majority stake in Ranbaxy Laboratories in ...

11.30 AM Apr 12th

Web Messenger

Platinum Member

209446 Followers

Sun Pharma  

Source:NDTV Profit - Sun Pharma will make an open offer worth Rs 18.4 crore to acquire a little over 28 per cent stake in Zenotech Laboratories Ltd. The proposal comes in the wake of Sun Pharma's proposed $4-billion deal to merge Ranbaxy Laboratories with itself as the

11.04 AM Apr 12th

News across the web »
Apr 23, 2014 at 12:46 | Source: Economic Times
Apr 18, 2014 at 14:36 | Source: Business Today
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.